Insider plans Rule 144 sale of 5,000 Exelixis (NASDAQ: EXEL) shares

Rhea-AI Filing Summary

Exelixis, Inc. insider plans Rule 144 sale of common stock. A holder has filed to sell 5,000 shares of Exelixis common stock through Morgan Stanley Smith Barney LLC on or around 02/12/2026 on the NASDAQ, with an aggregate market value of $216,250 at the time of the notice.

The shares were received as a gift from an affiliate, identified as Michael Morrissey/Morrissey Family Trust, on 11/11/2025, with the donor having originally acquired them on 10/02/2019. The filing notes 259,708,689 common shares outstanding, providing a baseline for the size of this planned sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	216250.00	259708689	02/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/11/2025	Gift from Affiliate	Michael Morrissey/Morrisey Family Trust		10/02/2019	5000		NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the EXEL Form 144 filing disclose?

The Form 144 discloses a planned sale of 5,000 Exelixis common shares. The shares are to be sold under Rule 144 on NASDAQ through Morgan Stanley, with an indicated aggregate market value of $216,250 based on the figures in the notice.

How many Exelixis (EXEL) shares are planned to be sold under this Form 144?

The filing covers a proposed sale of 5,000 shares of Exelixis common stock. These shares are listed with an aggregate market value of $216,250, giving investors a sense of the transaction’s approximate size at the time of the notice.

When are the EXEL shares expected to be sold according to the Form 144?

The notice lists an approximate sale date of 02/12/2026 for the 5,000 Exelixis shares. This is the date the filer expects to begin sales on NASDAQ, subject to market conditions and Rule 144 requirements described in the form.

How were the Exelixis (EXEL) shares being sold under Form 144 originally acquired?

The 5,000 Exelixis shares were acquired as a gift from an affiliate on 11/11/2025. The donor, identified as Michael Morrissey/Morrissey Family Trust, had originally acquired the securities on 10/02/2019, according to the acquisition table.

What does the EXEL Form 144 say about shares outstanding?

The notice states that 259,708,689 shares of Exelixis common stock were outstanding. This figure provides context for the relative size of the 5,000-share planned sale described in the filing under Rule 144.

Which broker will handle the planned EXEL stock sale under Rule 144?

The filing names Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the transaction. The broker’s New York address is listed, and the shares are expected to be sold on the NASDAQ exchange under Rule 144.